Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (7) , 1920-1925
- https://doi.org/10.1016/s0735-1097(99)00129-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) TrialJournal of the American College of Cardiology, 1998
- Evidence for an Adverse Interaction Between ACE Inhibitors and Aspirin Following Myocardial Infarction: The GUSTO-I TrialJournal of the American College of Cardiology, 1998
- Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteractionClinical Pharmacology & Therapeutics, 1998
- Aspirin as a Therapeutic Agent in Cardiovascular DiseaseCirculation, 1997
- Improvement of Alveolar–Capillary Membrane Diffusing Capacity With Enalapril in Chronic Heart Failure and Counteracting Effect of AspirinCirculation, 1997
- Interaction Between Enalapril and Aspirin on Mortality After Acute Myocardial Infarction: Subgroup Analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)The American Journal of Cardiology, 1997
- ACE Inhibitor Use in Patients With Myocardial InfarctionCirculation, 1995
- Is aspirin safe for patients with heart failure?Heart, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failureJournal of the American College of Cardiology, 1992